Clinical Trial Update: Mirabegron and Brown Adipose Tissue [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating mirabegron’s effect on brown adipose tissue in obesity. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Myrbetriq (mirabegron)

Snippet

Sponsor: Ingrid Jazet | Conditions: Obesity | Phase 4 | Status: UNKNOWN